The Perspective of Unani Medicine in Understanding Melasma – A Review

Arshan      Horti; Nazim      Husain; Shalina      Shaikh; Shaikh      Imran; Shaikh Nisar   Ahmed   Abbas; Khan Ameer   Kouser   Khan

doi:10.2174/0126667797282730240117071740

Abstract

Melasma, a prevalent hyperpigmentation skin disorder, poses significant challenges in dermatology clinics. Despite its global impact, conventional treatment options often entail potential side effects and limitations, necessitating the search for alternative therapeutic strategies.

This narrative review aims to advance the understanding of melasma from the perspective of Unani medicine, an ancient healing system recognized by the World Health Organization. It seeks to explore potential therapeutic avenues within the Unani medical paradigm by synergizing ancient wisdom with contemporary perspectives.

The review delves into the Unani scholars' understanding of melasma, known as Kalaf, drawing from the wisdom of renowned scholars. Their insights into the multifactorial etiology of melasma, including pathogenesis, treatment approach, and recommended prescriptions, are discussed.

The descriptions of melasma by Unani scholars have documented the etiopathogenesis, risk factors, and management in detail and emphasize personalized interventions based on the pathological concepts of Unani medicine. Moreover, some of these interventions were also investigated in recent clinical trials and found to have comparable efficacy with standard treatment options.

This review fosters the understanding of the pathogenesis of melasma according to Unani concepts and a holistic approach to the management of melasma, drawing from the timeless legacy of the Unani system of medicine. This review may serve as a reference point for future research, enabling the planning of subsequent studies on this disease with a comprehensive understanding of the previous investigations conducted in this field.

Keywords: Kalaf, pigmentary disorders, unani medicine, holistic medicine, melasma, hyperpigmentation skin disorder.

Graphical Abstract

[1]
Cosmetic DermatologyCosmetic Dermatology For Skin Of Color; McGraw Hill Education, 2009. 

[2]
Wolff, K.; Fitzpatricks Color Atlas, J.R. Fitzpatricks Color Atlas and Synopsis of Clinical Dermatology; McGraw Hill Education, 2009, pp. 344-346.

[3]
Gawkrodger, D.; Ardern-Jones, M.R. Dermatology An Illustrated Colour Text, 6th ed; Elsevier: New York, 2017. 

[4]
Raihan, A.; Kumaran, M.S. Study of contact sensitivity to cosmetic allergens in melasma. Pigment Int.,  2019, 6, 34-36.

[5]
Rashmi, S. Melasma A Monograph; Jaypee brothers: New Delhi, 2015. 

[6]
Jackson-Richards, D.; Pandya, A.G. Eds.;Dermatology for Skin of Color; Springer: New York, 2014, pp. 27-31.

[7]
Passeron, T.; Ortonne, J. Atlas of Pigmentary Disorders; Adis Cham, 2016. 
 [http://dx.doi.org/10.1007/978-3-319-10897-1]

[8]
Busam, K.J. Dermatopathology; Elsevier Saunders: USA, 2016, p. 270.

[9]
Goldman, L.; Ausiello, D.A. Cecil Textbook of Medicine; ELsevier, 2004. 

[10]
Shah, S.N. API Text Book of Medicine; The Association of Physicians of India: Mumbai, 2012. 

[11]
Majoosi, A.H.A.I.A. (Urdu translation by Kantoori GH). Kamilus Sana; Vol-2; Idara Kitabul Shifa: New Delhi, 2010. 

[12]
Jain, S. Dermatology Illustrated Study Guide and Comprehensive Board Review; Springer: New York, 2012, p. 137.

[13]
Baumann, L.; Saghari, S. Cosmetic Dermatology Principles and Practice; McGraw Hill Education, 2009. 

[14]

S, B. Oxford Handbook of Medical Dermatology; Oxford University Press: UK, 2016, p. 583.

[15]
Freedberg, I.M.; Eisen, A.Z.; Wolff, K.; Austen, K.F.; Goldsmith, L.A.; Fitzpatricks Dermatology, K.S.T. General Medicine; McGraw Hill Education: USA, 2003, pp. 977-978.

[16]
Grimes, P.E. Management of hyperpigmentation in darker racial ethnic groups. Semin. Cutan. Med. Surg.,  2009, 28(2), 77-85.
 [http://dx.doi.org/10.1016/j.sder.2009.04.001] [PMID: 19608057]

[17]
Suryakant, B.; Samipa, A.; Mukherjee, S.; Pralhadrao, B. Dermoscopy - histopathology correlation. In: Dermoscopy - Histopathology Correlation; Ankad, B.S.; Nikam, B.P.; Mukherjee, S.S., Eds.; Springer Nature: Singapore, 2021; pp. 163-183.

[18]
Wetter, D.A. Dermatology for Skin of Color. In: Mayo Clinic Proceedings; , 2014. 

[19]
Nicolaidou, E.; Antoniou, C.; Katsambas, A.D. Origin, clinical presentation, and diagnosis of facial hypermelanoses. Dermatol. Clin.,  2007, 25(3), 321-326, viii..
 [http://dx.doi.org/10.1016/j.det.2007.05.002] [PMID: 17662897]

[20]
Kang, H.Y.; Ortonne, J.P. What should be considered in treatment of melasma. Ann. Dermatol.,  2010, 22(4), 373-378.
 [http://dx.doi.org/10.5021/ad.2010.22.4.373] [PMID: 21165205]

[21]
Torres-Álvarez, B.; Mesa-Garza, I.G.; Castanedo-Cázares, J.P.; Fuentes-Ahumada, C.; Oros-Ovalle, C.; Navarrete-Solis, J.; Moncada, B. Histochemical and immunohistochemical study in melasma: Evidence of damage in the basal membrane. Am. J. Dermatopathol.,  2011, 33(3), 291-295.
 [http://dx.doi.org/10.1097/DAD.0b013e3181ef2d45] [PMID: 21317614]

[22]
Miot, L.D.; Miot, H.A.; Polettini, J.; Silva, M.G.; Marques, M.E. Morphologic changes and the expression of alpha-melanocyte stimulating hormone and melanocortin-1 receptor in melasma lesions: A comparative study. Am. J. Dermatopathol.,  2010, 32(7), 676-682.
 [http://dx.doi.org/10.1097/DAD.0b013e3181cd4396] [PMID: 20534990]

[23]
Bandyopadhyay, D. Topical treatment of melasma. Indian J. Dermatol.,  2009, 54(4), 303-309.
 [http://dx.doi.org/10.4103/0019-5154.57602] [PMID: 20101327]

[24]
Farshi, S. Comparative study of therapeutic effects of 20% azelaic acid and hydroquinone 4% cream in the treatment of melasma. J. Cosmet. Dermatol.,  2011, 10(4), 282-287.
 [http://dx.doi.org/10.1111/j.1473-2165.2011.00580.x] [PMID: 22151936]

[25]
Kaliterna, D. Melasma review of current treatment modalities and efficacy assessment of a new resorcinol-based topical formulation. Glob. Dermatol.,  2017, 2017(4), 1-6.

[26]
McKesey, J.; Tovar-Garza, A.; Pandya, A.G. Melasma treatment: An evidence-based review. Am. J. Clin. Dermatol.,  2020, 21(2), 173-225.
 [http://dx.doi.org/10.1007/s40257-019-00488-w] [PMID: 31802394]

[27]
Prignano, F.; Ortonne, J.P.; Buggiani, G.; Lotti, T. Therapeutical approaches in melasma. Dermatol. Clin.,  2007, 25(3), 337-342. [viii].
 [http://dx.doi.org/10.1016/j.det.2007.04.006] [PMID: 17662899]

[28]
Gupta, A.K.; Gover, M.D.; Nouri, K.; Taylor, S. The treatment of melasma: A review of clinical trials. J. Am. Acad. Dermatol.,  2006, 55(6), 1048-1065.
 [http://dx.doi.org/10.1016/j.jaad.2006.02.009] [PMID: 17097400]

[29]
Khatoon, F.; Husain, N.; Jabeen, A.; Uddin, Q.; Azahar, M.; Qureshi, A.; Khan, A.A. Psoriasis with special reference to Unani medicine - A review. Open Health,  2022, 3(1), 124-140.
 [http://dx.doi.org/10.1515/openhe-2022-0024]

[30]
Khatoon, F.; Azahar, M.; Jabeen, A.; Uddin, Q.; Husain, N.; Naikodi, M.A.R. Treatment of chronic plaque psoriasis with herbal Unani formulations: A randomized control trial of efficacy and safety. J. Ethnopharmacol.,  2022, 296, 115456.
 [http://dx.doi.org/10.1016/j.jep.2022.115456] [PMID: 35724745]

[31]
Doni, M.; Patel, M.I.; Khalid, M.; Husain, N.; Khan, M.Q.; Ayesha, B. Therapeutic evaluation of herbal formulation in acne vulgaris and its influence on quality of life-A single-arm clinical trial. J. Herb. Med.,  2022, 34, 100577.
 [http://dx.doi.org/10.1016/j.hermed.2022.100577]

[32]
 WHO Global Centre for Traditional Medicine. Available from:
          https://www.who.int/initiatives/who-global-centre-for-traditional-medicine  (Accessed Aug 6, 2023).

[33]
CCRUM.Unani System of Medicine: The Science of Health and Healing; department of ayUSH ministry of Health & family Welfare; , 2013. 

[34]
Ahmad, W.; Sofi, G.; Alam, M.A.; Zulkifle, M.; Ahmad, B. Understanding Holism in the light of principle underlying practice of Unani Medicine. Rev. Environ. Health,  2022, 37(2), 189-199.
 [http://dx.doi.org/10.1515/reveh-2021-0009] [PMID: 33984879]

[35]
Schmidt-Stiedenroth, K. Unani Medicine in the Making; Amsterdam University Press, 2020. 

[36]
Husain, N.; Khalid, M. Aesthetic significance of solah shringar (sixteen ornaments) in unani medicine.J. Complement. Altern. Med. Res.,  2021, 69-81.

[37]
Kapur, M. Basic principles of unani system. In: Psychological Perspectives on Childcare in Indian Indigenous Health Systems; Springer India: New Delhi, 2016; pp. 89-95.
 [http://dx.doi.org/10.1007/978-81-322-2428-0_7]

[38]
Imran, S.; Khalid, M.; Husain, N.; Khan, M.Q.; Shaikh, S. The efficacy of topical marham-e-akbar in chronic atopic dermatitis - an open-label interventional study. Drug Metab. Pers. Ther., 2022.

[39]
Husain, N.; Uddin, Q.; Kazmi, M.H.; Khalid, M. A non-inferiority randomized controlled clinical trial comparing Unani formulations and PUVAsol in non-segmental vitiligo. J. Complement. Integr. Med.,  2023, 20(1), 250-257.
 [http://dx.doi.org/10.1515/jcim-2021-0057] [PMID: 34162019]

[40]
Jagannathan, M.; Sadagopan, K.; Ekkarakudy, J.; Anandan, H. Clinico-epidemiological study of patients with melasma in a tertiary care hospital - A prospective study. Int. J. Sci. Stud.,  2017, 4, 117-120.

[41]
Tabri, R. Firdausul Hikmat; Idara Kitabul Shifa: New Delhi, 2010. 

[42]
Ahmad, H.H.J. Tazkira Tu Jaleel; CCRUM; Ministry of Health and Family Welfare, 2008. 

[43]
Tabri, A.M. Moalajat-e Buqratiya; CCRUM; Ministry of Health and Family Welfare, 1995. 

[44]
Razi, A.M.B.Z. Al Hawi Fil Tib; Saba Publishers, 1994. 

[45]
Quamri, A.M.H. Ghina Muna Ma Tarjuma Minhajul Ilaj; ssf CCRUM: New Delhi,Ministry of Health and Family Welfare, 2008. 

[46]
Majoosi, A. Kamilus Sana; CCRUM, 2010. 

[47]
Shirbeigi, L.; Ranjbar, M. Vascular Etiology of Melasma” the idea which was first presented by avicenna and rhazes. Tradit. Integr. Med.,  2016, 166-167.

[48]
Sina, I. Al Qanoon Fil Tib; Idara Kitabul Shifa: New Delhi, 2010. 

[49]
Zohar, I. Kitabul Taisir Fil Mudawat Wat Tadbir; Ministry of Health and Family Welfare, 1986. 

[50]
Baghdadi, I.H. Kitabul Makhtarat Fil Tib; CCRUM; Ministry of Health and Family Welfare, 2007. 

[51]
Jurjani, I. Zakheera Khawarzam Shahi; Idara Kitabul Shifa, 2010. 

[52]
Rizwan, H.K.A. Tarjuma Sharah Asbab; CCRUM, Ministry of Health and Family Welfare, Govt of India, 2010. 

[53]
Arzani, A. Tibbe Akbar; 

[54]
Khan, M.A. Akseere Azam; Idara Kitabush Shifa: New Delhi, 2011. 

[55]
Khan, H. Ajmal. Haziq; Madina Publication: Karachi, 1983. 

[56]
kabiruddin, M.. Bayaz e Kabir; Idara Kitabul Shifa: New Delhi, 2010. 

[57]
Handel, A.C.; Miot, L.D.B.; Miot, H.A. Melasma: A clinical and epidemiological review. An. Bras. Dermatol.,  2014, 89(5), 771-782.
 [http://dx.doi.org/10.1590/abd1806-4841.20143063] [PMID: 25184917]

[58]
Alexis, A.F. Skin of Color. In: A practical guide to dermatologic diagnosis and treatment; Springer, 2013. 

[59]
Trivedi, M.K.; Yang, F.C.; Cho, B.K. A review of laser and light therapy in melasma. Int. J. Womens Dermatol.,  2017, 3(1), 11-20.
 [http://dx.doi.org/10.1016/j.ijwd.2017.01.004] [PMID: 28492049]

[60]
Khanna, N. Illustrated synopsis of dermatology & sexually transmitted diseases; Elsevier, 2011. 

[61]
Mette Henriksen, R. Objective Determination of Fitzpatrick Skin Type. Dan. Med. Bull.,  2010, 57(8), B4153.

[62]
Ortonne, J.P.; Arellano, I.; Berneburg, M.; Cestari, T.; Chan, H.; Grimes, P.; Hexsel, D. Im, S.; Lim, J.; Lui, H.; Pandya, A.; Picardo, M.; Rendon, M.; Taylor, S.; Van Der Veen, J.P.W.; Westerhof, W. A global survey of the role of ultraviolet radiation and hormonal influences in the development of melasma. J. Eur. Acad. Dermatol. Venereol.,  2009, 23(11), 1254-1262.
 [http://dx.doi.org/10.1111/j.1468-3083.2009.03295.x] [PMID: 19486232]

[63]
Nayak, C.S.; Nouveau, S.; Agrawal, D.; Kohli, M.; Bernerd, F.; Misra, N. Skin hyperpigmentation in Indian population: Insights and best practice. Indian J. Dermatol.,  2016, 61(5), 487-495.
 [http://dx.doi.org/10.4103/0019-5154.190103] [PMID: 27688436]

[64]
Bhura, M.; Sharma, S. A clinico-epidemiological study on melasma: A prospective observation. Int. J. Health Clin. Res.,  2021, 4(3), 61-63.

[65]
Standard Unani Medical Terminology.Central Council For Research in Unani Medicine; New Delhi, 2012. 

[66]
Chandpuri, K. Mojizul Quanoon; Qaumi Council Bara-e Faroog-e Urdu Zaban: New Delhi, 1998. 

[67]
Mojtabaee, M.; Mokaberinejad, R.; Adhami, S.; Mansouri, P.; Rahbar, M. Nutritional advice for patients with melasma in iranian traditional medicine.J. Ski. Stem Cell.,  2016, 3.

[68]
Verma, K.; Kumre, K.; Sharma, H.; Singh, U. A study of various etiological factors in the causation of melasma. Indian J. Clin. Exp. Dermatol.,  2015, 1, 28-32.

[69]
Ahmad, SMR Review on melasma with special reference to treatment in unani medicine.Int. Pharm. Sci,  2013, 42-54.

[70]
Aquil, Z.; Khalid, M.; Uddin, Q. Potential role of unani medicinal plants in management of kalaf (Chloasma): A review. J. Skin,  2019, 3(1), 1-3.

[71]
Jamil, S.S.; Siddiqui, S.A.; Fazil, M. Standard Unani Treatment Guidelines for Common Diseases; Central Council for Research in Unani Medicine; CCRUM, 2014. 

[72]
Razi Zakaryya. Kitabul Hawi; VOL 21 par; CCRUM: New Delhi, 2007. 

[73]
Tabri, A.M. Moalajat Buqratiya; CCRUM, 1995. 

[74]
Mushtaq, S.; Sultana, A.; Nikhat, S.; Rehman, M. Concept of systemic cleansing through concoctives and purgatives (Munzij Mushil Therapy) as a regimen in chronic diseases. J. Med. Erud.,  2014, 2, 28-35.

[75]
Razi Zakaryya. Kitabul Fakhir Fit Tib; Vol-1; CCRUM: New Delhi, 2008. 

[76]
Antaki, D. Tazkirah Oolil Albab; CCRUM; Ministry of Health and Family Welfare, 2010. 

[77]
Khatoon, F.; Azahar, M.; Uddin, Q.; Husain, N.; Moin, M.S.; Khan, S. A comprehensive review on Trigonella foenum-graecum L. with special reference to Unani medicine. Comb. Chem. High Throughput Screen., 2023.
 [PMID: 37143276]

[78]
Shamsi, Y. Clinical evaluation of a topical unani pharmacopoeial formulation tila-e-kalf in the management of melasma (Kalf): A randomized controlled clinical trial. Orig. Res. Artic. AJP,  2022, 13, 255-264.

[79]
Qaiyyum, I.A.; Nawab, M.; Kazmi, M.H. A randomized controlled clinical trial to evaluate safety and efficacy of a Unani formulation in the management of Kalaf (Melasma). J. Complement. Integr. Med.,  2023, 20(1), 233-240.
 [http://dx.doi.org/10.1515/jcim-2021-0353] [PMID: 34582636]

[80]
Mahjour, M.; Banihashemi, M.; Rakhshandeh, H.; Vakili, V.; Khoushabi, A.; Kakhki, M.T. A triple-blind, randomized trial of a traditional compound as compared to 4% hydroquinone in melasma. J. Herb. Med.,  2020, 19, 100308.
 [http://dx.doi.org/10.1016/j.hermed.2019.100308]

[81]
Sultana, A.; Siddiquee, R.A.; Khanna, N.; Ahmad, T.; Shiffa, M. Comparative clinical evaluation of unani formulations in the treatment of melasma. Am. J. PharmTech Res,  2012, 2.

[82]
Gauri, M.; Ahmed, T.; Khan, M.S.; Ali, S.J. Therapeutic evaluation of unani herbal medicine for topical application (zimad of tukhme turb, tukhme karafs and sirka) in melasma (Kalaf) - A single blind randomized controlled study. Int. J. Sci. Res.,  2015, 4, 38-41.

[83]
Abdul-Latif, Z. Randomized clinical trial of unani formulations in chloasma/melasma. Hippocrat. J. Unani Med.,  2012, 7, 19-31.

[84]
Zarnigar, R. Evaluation of shooneez (Nigella Sativa) and sirka (Sugarcane Vinegar) in kalaf (Melasma). Hippocrat. J. Unani Med.,  2011, 6, 145-149.

Rights & Permissions Print Cite

Article Metrics

26

1

Journal Information

For Authors

For Editors

For Reviewers

Explore Articles

Open Access

Open Access Articles

For Visitors

DOI https://dx.doi.org/10.2174/0126667797282730240117071740	Print ISSN 2666-7797
Publisher Name Bentham Science Publisher	Online ISSN 2666-7800

Current Cosmetic Science

The Perspective of Unani Medicine in Understanding Melasma – A Review

Abstract

Graphical Abstract

Related Journals

Related Books